Embryo yield in dairy cattle after superovulation with Folltropin or Pluset

Autor: Mikkola, M., Taponen, J.

Publikováno v: In Theriogenology 15 January 2017 88:84-88

Situational and Individual Risk Factors for Cybercrime Victimization in a Cross-national Context.

Autor: Mikkola M; Tampere University, Tampere, Pirkanmaa, Finland., Oksanen A; Tampere University, Tampere, Pirkanmaa, Finland., Kaakinen M; University of Helsinki, Helsinki, Uusimaa, Finland., Miller BL; Clemson University, Clemson, SC, USA., Savolainen I; Tampere University, Tampere, Pirkanmaa, Finland., Sirola A; Tampere University, Tampere, Pirkanmaa, Finland., Zych I; University of Cordoba, Cordoba, Andalucía, Spain., Paek HJ; Hanyang University, Seongdong-gu, Seoul, South Korea.

Publikováno v: International journal of offender therapy and comparative criminology [Int J Offender Ther Comp Criminol] 2024 Apr; Vol. 68 (5), pp. 449-467. Date of Electronic Publication: 2020 Dec 10.

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.

Autor: Partanen A; Department of Medicine, Kuopio University Hospital, 70210 Kuopio, Finland., Waage A; Department of Hematology, St. Olavs Hospital, 7030 Trondheim, Norway., Peceliunas V; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital, 08661 Vilnius, Lithuania., Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, 0450 Oslo, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, 0316 Oslo, Norway., Anttila P; Helsinki University Hospital Cancer Center Hematology, University of Helsinki, 00029 Helsinki, Finland., Säily M; Hematology-Oncology Unit, Oulu University Hospital Hematology, 90220 Oulu, Finland., Uttervall K; Medical Unit Hematology, Karolinska University Hospital, 171 64 Solna, Sweden.; Department of Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden., Putkonen M; Department of Medicine, Turku University Hospital, 20521 Turku, Finland., Carlson K; Department of Hematology, Uppsala University Hospital, 751 85 Uppsala, Sweden., Haukas E; Stavanger University Hospital, 4011 Stavanger, Norway., Sankelo M; Hematology Unit, Department of Internal Medicine, Tampere University Hospital Hematology, 33520 Tampere, Finland., Szatkowski D; Department of Oncology, Hematology and Palliative Care, Foerde Central Hospital, 6812 Foerde, Norway., Hansson M; Department of Hematology, Skåne University Hospital, 222 42 Lund, Sweden., Marttila A; Department of Medicine, Kymenlaakso Central Hospital, 48210 Kotka, Finland., Svensson R; Department of Hematology, Linköping University Hospital, 581 85 Linköping, Sweden., Axelsson P; Department of Haematology, Helsingborg Hospital, 252 23 Helsingborg, Sweden., Lauri B; Department of Hematology, Sunderby Hospital, 971 80 Luleå, Sweden., Mikkola M; Department of Medicine, Päijät-Häme Central Hospital, 15850 Lahti, Finland., Karlsson C; Department of Haematology, Halland Hospital, 302 33 Halmstad, Sweden., Abelsson J; Department of Hematology, Uddevalla Hospital, 451 53 Uddevalla, Sweden., Ahlstrand E; Department of Medicine, Örebro University Hospital, 701 85 Örebro, Sweden., Sikiö A; Department of Medicine, Central Finland Central Hospital, 40620 Jyväskylä, Finland., Klimkowska M; Department of Clinical Pathology and Cytology, Karolinska University Hospital, 141 86 Stockholm, Sweden., Matuzeviciene R; Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Biomedical Sciences Institute, Vilnius University Hospital and Vilnius University Faculty of Medicine, 03101 Vilnius, Lithuania., Fenstad MH; Department of Immunology and Transfusion Medicine, St. Olavs Hospital, 7030 Trondheim, Norway., Ilveskero S; Clinical Chemistry, Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland., Pelliniemi TT; Fimlab Laboratories Ltd., 33520 Tampere, Finland., Nahi H; Hematology Centre, Karolinska University Hospital Huddinge, 141 57 Stockholm, Sweden., Silvennoinen R; Helsinki University Hospital Cancer Center Hematology, University of Helsinki, 00029 Helsinki, Finland.

Publikováno v: Cancers [Cancers (Basel)] 2024 Feb 29; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 29.

Ideal Theory, Epistemologies of Ignorance, and (Mis)Recognition

Autor: Mikkola, M., Giladi, P., McMillan, N.

Publikováno v: Epistemic Injustice and the Philosophy of Recognition ISBN: 9780429435133
Epistemic Injustice and the Philosophy of Recognition, 199-216
STARTPAGE=199;ENDPAGE=216;TITLE=Epistemic Injustice and the Philosophy of Recognition

In considering what makes epistemic injustice and epistemologies of ignorance wrongful, Matthew Congdon has recently argued that they involve forms of epistemic misrecognition in involving epistemic disrespect, disesteem, and neglect. Following Congd

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed65b74d60f5211068e59929c1574fc
https://doi.org/10.4324/9780429435133-10

[Review of: M.K. McGowan (2019) Just Words: On Speech and Hidden Harm]

Autor: Mikkola, M.

Publikováno v: The Philosophical Review, 130(3). Duke University Press

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::61928e13ff97e2c243fc9cbd6a33e428
https://dare.uva.nl/personal/pure/en/publications/review-of-mk-mcgowan-2019-just-words-on-speech-and-hidden-harm(a4e82e5d-a4a8-4f1b-9a13-0f85ff4b543b).html